Joseph M. Klausner

Isolated Limb Perfusion with Tumor Necrosis Factor and Melphalan for Limb Salvage in 186 Patients with Locally Advanced Soft Tissue Extremity Sarcomas

Alexander M.M. Eggermont, Heimen Schraffordt Koops, Joseph M. Klausner et al. · Annals of Surgery · 1996 · 457 citations · Full text

Medicine, Oncology, Surgery +16

An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer

Hagit Tulchinsky, Einat Shmueli, Arié Figer et al. · Annals of Surgical Oncology · 2008 · 304 citations

Medicine, Oncology, Surgery +15

The Role and Limitations of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography (FDG-PET) Scan and Computerized Tomography (CT) in Restaging Patients with Hepatic Colorectal Metastases Following Neoadjuvant Chemotherapy: Comparison with Operative and Pathological Findings

Nir Lubezky, Ur Metser, Ravit Geva et al. · Journal of Gastrointestinal Surgery · 2007 · 156 citations · Full text

Medicine, Oncology, Radiology +16

High dose tumor necrosis factor-? and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

Mordechai Gutman, Moshe Inbar, Dina Lev-Shlush et al. · Cancer · 1997 · 143 citations · Full text

Medicine, Oncology, Surgery +17

Lower Torso Ischemia-Induced Lung Injury Is Leukocyte Dependent

Joseph M. Klausner, Haim Anner, IAN S. PATERSON et al. · Annals of Surgery · 1988 · 137 citations

Medicine, Immunology, Pathology +14